Skip to main content
. 2020 Jul 20;4(14):3224–3233. doi: 10.1182/bloodadvances.2020001927

Table 5.

Association of donor and recipient rs1051792 genotypes with risks of GVHD and recurrent malignancy in the combined discovery and replication cohorts

End point Donor Recipient
HR (95% CI) P HR (95% CI) P
Grade 2-4 GVHD 0.96 (0.90-1.01) .13 1.00 (0.94-1.06) .98
Grade 3-4 GVHD 0.90 (0.81-1.01) .05 0.96 (0.87-1.07) .46
NRM after grade 3-4 GVHD 0.88 (0.76-1.01) .06 0.90 (0.78-1.03) .12
Chronic GVHD 1.00 (0.92-1.1) .99 1.03 (0.96-1.11) .38
Recurrent malignancy 1.00 (0.92-1.1) .99 1.01 (0.93-1.10) .78

All associations were tested in the allelic model.